Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2023 Earnin

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2023 Earnings Call Transcript February 6, 2024 Deciphera Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone, and welcome to Deciphera Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference […]

Related Keywords

Italy , Netherlands , France , China , Spain , Switzerland , Italian , Dan Martin , Tucker Kelly , Margarida Duarte , Steve Hoerter , Head Of International , European Union , Patient Assistance Program , Zai Lab In Greater China , Inflation Reduction , Zai Lab , Eastern Europe , Chief Financial Officer , Quality Tea Brands , Gold Stocks For , Deciphera Pharmaceuticals , Nc , Fourth Quarter , Chief Commercial Officer , Financial Results , Matt Sherman , Qinlock , Mist , Chief Executive Officer , Ben Larson ,